Results 111 to 120 of about 880 (162)

Mapping multimodal phenotypes to perturbations in cells and tissue with CRISPRmap. [PDF]

Nat Biotechnol
Gu J, Iyer A, Wesley B, Taglialatela A, Leuzzi G, Hangai S, Decker A, Gu R, Klickstein N, Shuai Y, Jankovic K, Parker-Burns L, Jin Y, Zhang JY, Hong J, Niu X, Costa JA, Pezet MG, Chou J, Chen C', Paiva M, Snoeck HW, Landau DA, Azizi E, Chan EM, Ciccia A, Gaublomme JT.   +26 more
europepmc   +1 more source

Efficacy and safety of different regimens of neoadjuvant therapy in patients with hormone receptor-positive, her2-negative breast cancer: a network meta-analysis. [PDF]

Front Immunol
Wu Y, Huang S, Wei Y, Huang M, Li C, Liang W, Qin T.   +6 more
europepmc   +1 more source

The Next Generation of Dashboards: a Spatial Online Analytical Processing (SOLAP) Platform for COVID-19. [PDF]

J Maps
Haynes D, Ahmadkhani M, Numainville J.
europepmc   +1 more source

PARP1-DOT1L transcription axis drives acquired resistance to PARP inhibitor in ovarian cancer. [PDF]

Mol Cancer
Liu C, Li J, Xu F, Chen L, Ni M, Wu J, Zhao H, Wu Y, Li J, Wu X, Chen X.   +10 more
europepmc   +1 more source

Data Lake, Data Warehouse, Datamart, and Feature Store: Their Contributions to the Complete Data Reuse Pipeline.

JMIR Med Inform
Lamer A, Saint-Dizier C, Paris N, Chazard E.   +3 more
europepmc   +1 more source

Transcription-replication conflicts underlie sensitivity to PARP inhibitors. [PDF]

Nature
Petropoulos M, Karamichali A, Rossetti GG, Freudenmann A, Iacovino LG, Dionellis VS, Sotiriou SK, Halazonetis TD.   +7 more
europepmc   +1 more source

Genome-wide CRISPR-Cas9 screening identifies CLK1 inhibition as a strategy to restore PARP inhibitor sensitivity via ERCC1 isoform switching. [PDF]

Protein Cell
Liu C, Xu F, Wu Y, Li J, Ni M, Xia S, Chen L, Zhao H, Yu M, Zhou Y, Zhang M, Li J, Wu X, Huang Y, Zhu T, Chen X.   +15 more
europepmc   +1 more source

Engineered chromatin readers track damaged chromatin dynamics in live cells and animals. [PDF]

Nat Commun
da Silva RC, Eleftheriou K, Recchia DC, Portegijs V, Ten Bulte D, Kupfer N, Vroegindeweij-de Wagenaar NP, Vergara X, Ouchene A, van den Heuvel S, Baubec T.   +10 more
europepmc   +1 more source

Significance of homologous recombinant deficiency as a biomarker for drug sensitivity in colorectal cancer. [PDF]

Br J Cancer
Kato Y, Seishima R, Hattori K, Kato H, Ishida H, Shigeta K, Okabayashi K, Sugihara E, Takimoto T, Nakamura K, Nishihara H, Saya H, Kitagawa Y.   +12 more
europepmc   +1 more source

SmellyCode++: Multi-Label Dataset for Code Smell Detection. [PDF]

Sci Data
Alomari N, Alazba A, Aljamaan H, Alshayeb M.   +3 more
europepmc   +1 more source